Article info

Original research
Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients

Authors

  1. Correspondence to Professor Tetsuya Amano, Cardiology, Aichi Medical University, Nagakute 480-1195, Japan; amanot{at}aichi-med-u.ac.jp
View Full Text

Citation

Onishi T, Nakano Y, Hirano K, et al
Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients

Publication history

  • Received June 27, 2020
  • Revised August 21, 2020
  • Accepted August 25, 2020
  • First published September 30, 2020.
Online issue publication 
December 22, 2020

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.